BPC-157 for post-surgery recovery: what the evidence actually says

What did @averyfisk_ actually say?

After 13 shoulder dislocations and labrum surgery, @averyfisk_ says BPC-157 did what physical therapy couldn't. The core claim: "within just six weeks, the inflammation that I've had for years started disappearing," and after six months, his joints were in "better shape than before" the injury. He also says he injected it locally, near the injury site, and credits that targeting as part of why it worked.

He's upfront that he was skeptical of claims that BPC-157 could "heal you pretty much instantly," then reverses course and says those claims turned out to be true. That's worth noting. He came in doubting, reported a positive outcome, and mixed in physical therapy and what sounds like modified training. That's not a controlled experiment. That's a person recovering from surgery while doing several things at once.

Does the science back this up?

Partially, and with serious caveats. BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. The preclinical data is genuinely interesting. Animal studies show it promotes tendon-to-bone healing, reduces inflammation, and may upregulate growth hormone receptors in injured tissue. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated healing of tendons, ligaments, and muscle in rodent models.

Here's the problem: almost none of this has been replicated in human clinical trials. There are no peer-reviewed, randomized controlled trials in humans demonstrating that BPC-157 repairs labrum tissue, eliminates chronic joint inflammation in six weeks, or improves mobility beyond what surgery and physical therapy would produce. The claim that results were "actually the truth" is being made without the clinical evidence to support it in a human population. Rodent healing physiology is not a reliable proxy for post-surgical human recovery.

What did they get wrong (or right)?

He got the skepticism framing right, then abandoned it. Starting out cautious and then concluding "it was actually the truth" based on personal experience is not how you validate a compound that lacks human trial data. That said, a few things he said are reasonable.

• Local injection near an injury site is how BPC-157 is typically administered in animal studies, so he's not making that up.
• Combining it with modified training and physical therapy is sensible. The problem is he can't separate which intervention drove his recovery.
• His claim that muscles grew faster than connective tissue "while on cycle" is biologically plausible. Anabolic steroid use is associated with disproportionate muscle hypertrophy relative to tendon and ligament adaptation, a pattern documented by Seynnes et al. (2009, Journal of Applied Physiology).

What he got wrong: attributing his recovery primarily to BPC-157 when he had labrum surgery, physical therapy, and training modifications running concurrently. He also repeats the claim about near-instant healing without flagging that this is not supported by any human study.

What should you actually know?

BPC-157 is not FDA-approved. It is not legal to market as a dietary supplement or drug in the United States. It exists in a regulatory gray zone where some compounding pharmacies have dispensed it, but the FDA issued guidance in 2022 effectively removing it from the list of substances eligible for compounding under 503A and 503B pathways. That matters if you're considering it.

The preclinical data is interesting enough that researchers are watching it. Huang et al. (2015, Journal of Orthopaedic Surgery and Research) showed improved collagen organization and tensile strength in rat Achilles tendons after BPC-157 treatment. That's a real finding. But "works in rats" has a poor track record of translating to human therapeutics, particularly for musculoskeletal repair. Six weeks of inflammation reduction in a post-surgical patient who is also doing physical therapy and modifying his training tells us essentially nothing about what BPC-157 did on its own.

If you're post-surgery and curious about adjunctive recovery strategies, that conversation belongs with a sports medicine physician or orthopedic specialist who can evaluate your specific case, not a TikTok testimonial from someone whose recovery involved multiple simultaneous interventions.

Bottom line

@averyfisk_ had a positive recovery experience. That's real and worth acknowledging. But a single anecdote from a post-surgical patient doing physical therapy, modifying training, and using a peptide simultaneously cannot tell us what caused the improvement. The science on BPC-157 is promising in animal models and essentially absent in humans. Anyone treating this video as evidence that BPC-157 will fix their shoulder is making a significant inferential leap that the data does not support.